newsfilter
← Latest News
PR Newswire·

resTORbio and TrialSpark collaborate to investigate RTB-101 for COVID-19 on the Project Covalence platform

TrialSpark, a tech-enabled drug development partner committed to improving the speed, quality, and innovation of clinical trials, today announced a...